GT

Golap Talukdar

Director Director DIN 08376301
DIN 08376301 First appointment Mar 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2019
Shareholding value Locked Premium profile

About Golap Talukdar

Golap Talukdar has 7 years in corporate governance. Formerly with 1 company, such as Kangrin And Boqe Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08376301
Primary Designation Director
First Appointment 11 Mar 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 11 Mar 2019 2003 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kangrin And Boqe Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Golap Talukdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Golap Talukdar

Golap Talukdar has 7 years in corporate governance. Formerly with 1 company, such as Kangrin And Boqe Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Golap Talukdar is associated with 0 companies as a director.

Golap Talukdar has expertise in General Business.

Golap Talukdar has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available